Demonstration to Increase Hydroxyurea Prescribing for Children with Sickle Cell Disease Through Provider Incentives

This notice solicits applications to demonstrate the feasibility and effectiveness of providing financial incentives to providers to improve the quality of life of children with sickle cell disease (SCD) through increased prescription rates of hydroxyurea.

This initiative is not issued or funded
by the Centers for Medicare and Medicaid Services (CMS).
Related Programs

Community Programs to Improve Minority Health Grant Program

Department of Health and Human Services



Who's Eligible


Relevant Nonprofit Program Categories

G02.13.03
HIV/AIDS


Obtain Full Opportunity Text:
Demonstration to Increase Hydroxyurea Prescribing for Children with Sickle Cell Disease Through Provider Incentives

Additional Information of Eligibility:
• State Governments • County Governments • City or township governments • Special district governments • Independent school districts • Public and State controlled institutions of higher education • Native American tribal governments (Federally recognized) • Public Housing authorities/Indian housing authorities • Native American tribal organizations (other than federally recognized tribal governments) • Nonprofits having 501(c)(3) status with the IRS, other than institutions of higher education • Nonprofits without 501(c)(3) status with the IRS, other than institutions of higher education • Private non-profit institutions of higher education • U. S. Territories

Full Opportunity Web Address:
https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=67220

Contact:


Agency Email Description:
Grants.gov Customer Support

Agency Email:


Date Posted:
2020-07-28

Application Due Date:


Archive Date:
2020-09-26




301 Moved Permanently

Moved Permanently

The document has moved here.